Sessler DI, Riedel B. Anesthesia and cancer recurrence: context for divergent study outcomes. Anesthesiology 2019; 130: 3–5. doi: <a href="https://doi.org/10.1097/ALN.0000000000002506" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/ALN.0000000000002506</a>
Margraf A, Ludwig N, Zarbock A, Rossaint J. Systemic inflammatory response syndrome after surgery: mechanisms and protection. Anesth Analg 2020; 131: 1693–707. doi: <a href="https://doi.org/10.1213/ANE.0000000000005175" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1213/ANE.0000000000005175</a>
Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 2012; 130: 1237–50. doi: <a href="https://doi.org/10.1002/ijc.26448" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/ijc.26448</a>
Egger G. [Acute inflammation: basics, pathophysiology and clinical manifestations of non-specific imunity]. [German]. Wien, New York: Springer Verlag; 2005.
Potočnik I, Novak-Janković V, Šostarič M, Jerin A, Štupnik T, Skitek M, et al. Antiinflammatory effect of sevoflurane in open lung surgery with one-lung ventilation. Croat Med J 2014; 55: 628–37. doi: <a href="https://doi.org/10.3325/cmj.2014.55.628" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3325/cmj.2014.55.628</a>
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021; 47: 1181–247. doi: <a href="https://doi.org/10.1007/s00134-021-06506-y" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00134-021-06506-y</a>
Colucci DG, Puig NR, Hernandez-Pand R. Influence of anaesthetic drugs on immune response: from inflammation to immunosuppression. OA Anaesthetics 2013; 30: 21. doi: <a href="https://doi.org/10.13172/2052-7853-1-3-1091" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.13172/2052-7853-1-3-1091</a>
Crozier TA, Müller JE, Quittkat D, Sydow M, Wuttke W, Kettler D. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994; 72: 280–5. doi: <a href="https://doi.org/10.1093/bja/72.3.280" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/bja/72.3.280</a>
Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 1988; 263: 6177–82. PMID: 2452159
Dubowitz JA, Cata JP, De Silva AP, Braat S, Shan D, Yee K, et al. Global Onco-Anaesthesia Research Collaboration Group. Volatile anaesthesia and peri-operative outcomes related to cancer: a feasibility and pilot study for a large, randomised control trial. Anaesthesia 2021; 76: 1198–206. doi: <a href="https://doi.org/10.1111/anae.15354" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/anae.15354</a>
Galoș EV, Tat TF, Popa R, Efrimescu CI, Finnerty D, Buggy DJ, et al. Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trial. Br J Anaesth 2020; 125: 712–21. doi: <a href="https://doi.org/10.1016/j.bja.2020.05.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.bja.2020.05.003</a>
Novak-Jankovič V, Paver-Eržen V, Bovill JG, Ihan A, Osredkar J. Effect of epidural and intravenous clonidine on the neuro-endocrine and immune stress response in patients undergoing lung surgery. Eur J Anaesthesiol 2000;17: 50–6. doi:<a href="https://doi.org/10.1046/j.1365-2346.2000.00602.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1365-2346.2000.00602.x</a>
Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev 2018; 98: 1477–504. doi: <a href="https://doi.org/10.1152/physrev.00039.2016" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1152/physrev.00039.2016</a>
Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 2006; 8: 383–95. doi: <a href="https://doi.org/10.31887/DCNS.2006.8.4/ssmith" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.31887/DCNS.2006.8.4/ssmith</a>
Velkeniers B., Dogusan Z., Naessens F. et al. Prolactin, growth hormone and the immune system in humans. Cell Mol Life Sci 1998; 54: 1102–8. doi: <a href="https://doi.org/10.1007/s000180050239" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s000180050239</a>
Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A, et al; Breast Cancer Recurrence Collaboration. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet 2019; 394: 1807–15. doi: <a href="https://doi.org/10.1016/S0140-6736(19)32313-X" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0140-6736(19)32313-X</a>
Du YT, Li YW, Zhao BJ, Guo XY, Feng Y, Zuo MZ, Fu C, et al; Peking University Clinical Research Program Study Group. Long-term survival after combined epidural-general anesthesia or general anesthesia alone: follow-up of a randomized trial. Anesthesiology 2021; 135: 233–45. doi: <a href="https://doi.org/10.1097/ALN.0000000000003835" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/ALN.0000000000003835</a>
Xu ZZ, Li HJ, Li MH, Huang SM, Li X, Liu QH, et al. Epidural anesthesia-analgesia and recurrence-free survival after lung cancer surgery: a randomized trial. Anesthesiology 2021; 135: 419–32. doi: <a href="https://doi.org/10.1097/ALN.0000000000003873" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/ALN.0000000000003873</a>
Potočnik I, Hostnik A, Markovič-Božič J. Do inhalational anesthetic agents still hold their place in modern anesthesia practice? Signa Vitae 2019; 15: 14–17. doi: <a href="https://doi.org/10.22514/SV152.092019.1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.22514/SV152.092019.1</a>
Markovic-Bozic J, Karpe B, Potocnik I, Jerin A, Vranic A, Novak-Jankovic V. Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy. BMC Anesthesiol 2016; 16: 18. doi: <a href="https://doi.org/10.1186/s12871-016-0182-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s12871-016-0182-5</a>
Jiao B, Yang C, Huang NN, Yang N, Jia Wei J, Xu H. Relationship between volatile anesthetics and tumor progression: unveiling the mystery. Curr Med Sci 2018; 38: 962–7. doi: <a href="https://doi.org/10.1007/s11596-018-1970-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s11596-018-1970-6</a>
Zhang L, Zhang J, Yang L, Dong Y, Zhang Y, Xie Z. Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells. Br J Anaesth 2013; 110(Suppl 1): i82–91. doi: <a href="https://doi.org/10.1093/bja/aet115" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/bja/aet115</a>
Ulbrich F, Eisert L, Buerkle H, Goebel U, Schallner N. Propofol, but not keta-mine or midazolam, exerts neuroprotection after ischemic injury by inhibition of Toll-like receptor 4 and nuclear factor kappa-light-chain-enhancer of activated B-cell signalling. A combined in vitro study and animal study. Eur J Anaesthesiol 2016; 33: 670–80. doi: <a href="https://doi.org/10.1097/EJA.0000000000000449" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/EJA.0000000000000449</a>
Sun C, Liu P, Pei L, Zhao M, Huang Y. Propofol inhibits proliferation and augments the anti-tumor effect of doxorubicin and paclitaxel partly through promoting ferroptosis in triple-negative breast cancer cells. Front Oncol 2022; 12: 837974. doi: <a href="https://doi.org/10.3389/fonc.2022.837974" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3389/fonc.2022.837974</a>
El Azab SR, Rosseel PM, De Lange JJ, van Wijk EM, van Strik R, Scheffer GJ. Effect of VIMA with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgery. Eur J Anaesthesiol 2002; 19: 276–82. doi: <a href="https://doi.org/10.1017/s0265021502000443" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1017/s0265021502000443</a>
Minou AF, Dzyadzko AM, Shcherba AE, Rummo OO. The influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipients. Anesthesiol Res Pract 2012; 2012: 930487. doi: <a href="https://doi.org/10.1155/2012/930487" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1155/2012/930487</a>
Jabaudon M, Zhai R, Blondonnet R, Bonda WLM. Inhaled sedation in the intensive care unit. Anaesth Crit Care Pain Med 2022; 41: 101133. doi: <a href="https://doi.org/10.1016/j.accpm.2022.101133" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.accpm.2022.101133</a>
Song Z, Tan J. Effects of anesthesia and anesthetic techniques on metastasis of lung cancers: a narrative review. Cancer Manag Res 2022; 14: 189–204. doi: <a href="https://doi.org/10.2147/CMAR.S343772" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2147/CMAR.S343772</a>
Oh CS, Park HJ, Piao L, Sohn KM, Koh SE, Hwang DY, et al. Expression profiles of immune cells after propofol or sevoflurane anesthesia for colorectal cancer surgery: a prospective double-blind randomized trial. Anesthesiology 2022; 136: 448–58. doi: <a href="https://doi.org/10.1097/ALN.0000000000004119" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/ALN.0000000000004119</a>
Quan Y, Li S, Wang Y, Liu G, Lv Z, Wang Z. Propofol and sevoflurane alleviate malignant biological behavior and cisplatin resistance of Xuanwei lung adenocarcinoma by modulating the Wnt/β-catenin pathway and PI3K/AKT athway. Anticancer Agents Med Chem 2022; 22: 2098–2108. doi: <a href="https://doi.org/10.2174/1871520621666211026092405" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2174/1871520621666211026092405</a>
Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B; Global Onco-Anesthesia Research Collaboration Group. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 2019; 66: 546–61. doi: <a href="https://doi.org/10.1007/s12630-019-01330-x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s12630-019-01330-x</a>
Maalouf M, Reddy AJ, Mazboudi P, Min M, Rawal R, Curow CA, et al. An analysis of lidocaine usage in the treatment of squamous cell carcinoma. Cureus 2023; 15: e35614. doi: <a href="https://doi.org/10.7759/cureus.35614" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.7759/cureus.35614</a>
Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, et al. Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology 2017; 126: 868–81. doi: <a href="https://doi.org/10.1097/ALN.0000000000001528" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/ALN.0000000000001528</a>
Zhao L, Ma N, Liu G, Mao N, Chen F, Li J. Lidocaine inhibits hepatocellular carcinoma development by modulating circ_ITCH/miR-421/CPEB3 axis. Dig Dis Sci 2021; 66: 4384–97. doi: <a href="https://doi.org/10.1007/s10620-020-06787-1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s10620-020-06787-1</a>
Zhang H, Yang L, Zhu X, Zhu M, Sun Z, Cata JP, et al. Association between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study. Br J Anaesth 2020; 125: 141–8. doi: <a href="https://doi.org/10.1016/j.bja.2020.03.034" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.bja.2020.03.034</a>
Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J. Risk of second breast cancer events with chronic opioid use in breast cancer survivors. Pharmacoepidemiol Drug Saf 2019; 28: 740–53. doi: <a href="https://doi.org/10.1002/pds.4779" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/pds.4779</a>
Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose timing study. Neuroimmunomodulation 2004; 11: 255–60. doi: <a href="https://doi.org/10.1159/000078444" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1159/000078444</a>
Forget P, Berlière M, Poncelet A, De Kock M. Effect of clonidine on oncological outcomes after breast and lung cancer surgery. Br J Anaesth 2018; 121: 103–4. doi: <a href="https://doi.org/10.1016/j.bja.2018.04.020" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.bja.2018.04.020</a>
Zhang Y, Li M, Cui E, Zhang H, Zhu X, Zhou J, et al. Dexmedetomidine attenuates sevoflurane induced neurocognitive impairment through α2 adrenoceptors. Mol Med Rep 2021; 23: 38. doi: <a href="https://doi.org/10.3892/mmr.2020.11676" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3892/mmr.2020.11676</a>
Musselman RP, Bennett S, Li W, Mamdani M, Gomes T, van Walraven C, et al. Association between perioperative beta blocker use and cancer survival following surgical resection. Eur J Surg Oncol 2018; 44: 1164–69. doi: <a href="https://doi.org/10.1016/j.ejso.2018.05.012" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejso.2018.05.012</a>
Kalfeist L, Galland L, Ledys F, Ghiringhelli F, Limagne E, Ladoire S. Impact of glucocorticoid use in oncology in the immunotherapy era. Cells 2022; 11: 770. doi: <a href="https://doi.org/10.3390/cells11050770" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/cells11050770</a>